Smith & Nephew: Market Segment Forecasts and Company Strategic Assessment
A strategic assessment of Smith & Nephew, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global orthopedics market.
Contains 37 pages
Contains 37 pages
SECTION 1: BUSINESS EVOLUTION AND ORGANIZATION
SECTION 2: FACILITIES AND EMPLOYEES
SECTION 3: TECHNOLOGICAL KNOW-HOW
SECTION 4: PRODUCT PORTFOLIO
SECTION 5: MARKETING TACTICS
SECTION 6: R&D EXPENDITURES AND MAJOR PROGRAMS
SECTION 7: STRATEGIC DIRECTION
SECTION 2: FACILITIES AND EMPLOYEES
SECTION 3: TECHNOLOGICAL KNOW-HOW
SECTION 4: PRODUCT PORTFOLIO
SECTION 5: MARKETING TACTICS
SECTION 6: R&D EXPENDITURES AND MAJOR PROGRAMS
SECTION 7: STRATEGIC DIRECTION
More Publications
2017 Emerging Clinical Chemistry and Immunodiagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
US$ 3,465.00
January 2017
320 pages
2016-2020 Emerging Coagulation Testing Technologies and Strategic Profiles of Leading Suppliers
US$ 3,080.00
March 2016
124 pages
2023 RSV Diagnostics Market: USA, Europe, Japan-Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment-Hospitals, Commercial and Public Health Labs, POC Locations
US$ 1,500.00
August 2023
-
2015-2019 World Clinical Chemistry and Immunodiagnostics Market: Country Forecasts and Strategic Profiles of Leading Suppliers
US$ 2,800.00
June 2015
50 pages
